BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32453516)

  • 1. More on Neurologic Features in Severe SARS-CoV-2 Infection.
    Sarikaya B
    N Engl J Med; 2020 Jun; 382(26):e110. PubMed ID: 32453516
    [No Abstract]   [Full Text] [Related]  

  • 2. More on Neurologic Features in Severe SARS-CoV-2 Infection.
    Larvie M; Lev MH; Hess CP
    N Engl J Med; 2020 Jun; 382(26):e110. PubMed ID: 32453515
    [No Abstract]   [Full Text] [Related]  

  • 3. More on Neurologic Features in Severe SARS-CoV-2 Infection. Reply.
    Helms J; Kremer S; Meziani F
    N Engl J Med; 2020 Jun; 382(26):e110. PubMed ID: 32453517
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurological manifestations in COVID-19 caused by SARS-CoV-2.
    Baig AM
    CNS Neurosci Ther; 2020 May; 26(5):499-501. PubMed ID: 32266761
    [No Abstract]   [Full Text] [Related]  

  • 5. [SARS-CoV-2 infection: do not neglect neurological symptoms!].
    Pouga L
    Rev Prat; 2020 May; 70(5):532-536. PubMed ID: 33058643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurologic complications of coronavirus infections.
    Nath A
    Neurology; 2020 May; 94(19):809-810. PubMed ID: 32229625
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurological manifestations of COVID-19, SARS and MERS.
    Verstrepen K; Baisier L; De Cauwer H
    Acta Neurol Belg; 2020 Oct; 120(5):1051-1060. PubMed ID: 32562214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on neurological manifestations of COVID-19.
    Yavarpour-Bali H; Ghasemi-Kasman M
    Life Sci; 2020 Sep; 257():118063. PubMed ID: 32652139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurologic manifestations and COVID-19.
    Wiwanitkit V
    Gac Med Mex; 2020; 156(4):366. PubMed ID: 32831331
    [No Abstract]   [Full Text] [Related]  

  • 10. SARS-CoV-2 Infection Leads to Neurological Dysfunction.
    Acharya A; Kevadiya BD; Gendelman HE; Byrareddy SN
    J Neuroimmune Pharmacol; 2020 Jun; 15(2):167-173. PubMed ID: 32447746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System.
    De Felice FG; Tovar-Moll F; Moll J; Munoz DP; Ferreira ST
    Trends Neurosci; 2020 Jun; 43(6):355-357. PubMed ID: 32359765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System.
    Abboud H; Abboud FZ; Kharbouch H; Arkha Y; El Abbadi N; El Ouahabi A
    World Neurosurg; 2020 Aug; 140():49-53. PubMed ID: 32474093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) on the nervous system. What can we expect from SARS -CoV-2?
    Monroy-Gómez J; Torres-Fernández O
    Biomedica; 2020 Oct; 40(Supl. 2):173-179. PubMed ID: 33152201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection.
    Chaumont H; San-Galli A; Martino F; Couratier C; Joguet G; Carles M; Roze E; Lannuzel A
    J Neurol; 2020 Nov; 267(11):3121-3127. PubMed ID: 32533322
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurological complications of coronavirus and COVID-19.
    Carod-Artal FJ
    Rev Neurol; 2020 May; 70(9):311-322. PubMed ID: 32329044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological associations of COVID-19.
    Ellul MA; Benjamin L; Singh B; Lant S; Michael BD; Easton A; Kneen R; Defres S; Sejvar J; Solomon T
    Lancet Neurol; 2020 Sep; 19(9):767-783. PubMed ID: 32622375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SARS-CoV-2 (COVID-19) as a predictor of neuroinflammation and neurodegeneration: potential therapy strategies].
    Putilina MV; Grishin DV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8. Vyp. 2):58-64. PubMed ID: 33016678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.
    Zubair AS; McAlpine LS; Gardin T; Farhadian S; Kuruvilla DE; Spudich S
    JAMA Neurol; 2020 Aug; 77(8):1018-1027. PubMed ID: 32469387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Commentary on "A comparative overview of COVID-19, MERS and SARS: Review article" (International Journal of Surgery 2020; 81:1-8).
    Awais S; Shah SFH; Shah SGS
    Int J Surg; 2020 Nov; 83():28-29. PubMed ID: 32927142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.